Polysorbate 80 and polymyxin B inhibit Stenotrophomonas maltophilia biofilm

Adam M Malinowski1, Bryan M McClarty1, Carolyn Robinson1

  • 1Department of Biological Sciences, College of Science & Health, DePaul University, Chicago, IL 60614.

Insights

Polysorbate 80 and polymyxin B effectively inhibit Stenotrophomonas maltophilia growth and biofilm formation. This combination shows promise for combating drug-resistant bacterial infections on medical devices.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biomedical Engineering

Background:

  • Stenotrophomonas maltophilia is a multidrug-resistant opportunistic pathogen.
  • This bacterium frequently colonizes implanted medical devices by forming biofilms.
  • Biofilm formation poses significant challenges in clinical settings.

Purpose of the Study:

  • To investigate the inhibitory effects of polysorbate 80 and polymyxin B on Stenotrophomonas maltophilia.
  • To evaluate the efficacy of these agents, alone and in combination, against bacterial growth and biofilm development.

Main Methods:

  • Minimum Inhibitory Concentration (MIC) assays were performed.
  • Biofilm formation assays were conducted.
  • The activity of sub-inhibitory concentrations (subMIC) of polysorbate 80 and polymyxin B was assessed.

Main Results:

  • Polysorbate 80 and polymyxin B demonstrated inhibitory activity against S. maltophilia.
  • A combination of subMIC polymyxin B and polysorbate 80 was significantly more effective than individual agents.
  • The combination treatment markedly reduced bacterial growth and inhibited biofilm formation.

Conclusions:

  • Combined subMIC polymyxin B and polysorbate 80 represent a potent strategy to control S. maltophilia.
  • This approach may offer a novel therapeutic option for preventing or treating infections associated with medical devices.
  • Further research is warranted to explore clinical applications of this synergistic combination.